Riskpilot← Back to searchSign inGet full accessTERAPIBYGG AS
ASActiveOrg 987554339Slettevikvegen 1, 5124 MorvikRental and operating of own or leased real estate · NACE 6820Est. 20040 employees
Revenue 2024
NOK 655K
+5% vs 2023
EBITDA margin
90.6%
+7% vs 2023
Equity ratio
3.2%
Financial strength
Net profit 2024
NOK 238K
+7% vs 2023
| Revenue | NOK 655K | +5% |
| EBITDA | NOK 593K | +7% |
| Net profit | NOK 238K | +7% |
| Total assets | NOK 3,2M | -5% |
| Equity | NOK 101K | -93% |
| Employees | 0 | — |
Legal name
TERAPIBYGG AS
Org number
987554339
Legal form
Aksjeselskap
NACE code
6820 · Rental and operating of own or leased real estate
Founded
1. desember 2004
Share capital
NOK 100 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styret i fellesskap.
Company purpose
Eie fast eiendom. Herunder eiersjoner. Samt drift og utleie av slik eiendom og dertil tilhørende oppgaver.
Address
Slettevikvegen 1, 5124 Morvik
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 556 | 561 | 541 | 625 | 655 |
| Staff expenses | −0 | −0 | −0 | −20 | −20 |
| EBITDA | 232 | 513 | 429 | 554 | 593 |
| Depreciation & amort. | −137 | −137 | −137 | −137 | −137 |
| EBIT | 95 | 376 | 292 | 417 | 456 |
| Net financials | −100 | −87 | −99 | −118 | −138 |
| Profit before tax | −5 | 289 | 194 | 299 | 319 |
| Tax | 6 | 71 | 63 | 75 | 81 |
| Net profit | −11 | 218 | 131 | 223 | 238 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 3 620 | 3 506 | 3 254 | 3 339 | 3 176 |
| Equity | 1 151 | 1 229 | 1 160 | 1 383 | 101 |
| Long-term debt | 2 407 | 2 153 | 1 900 | 1 647 | 2 589 |
| Short-term debt | 62 | 123 | 194 | 309 | 485 |
| Total debt | 2 468 | 2 277 | 2 094 | 1 956 | 3 074 |
EBITDA margin
90.6%
This company
15.8%
Market median
+473% vs market
20202024
Equity ratio
3.2%
This company
38.2%
Market median
-92% vs market
20202024
Return on equity
234.9%
This company
18.4%
Market median
+1177% vs market
20202024
Net profit margin
36.3%
This company
8.1%
Market median
+348% vs market
20202024
Asset turnover
0.21×
This company
1.12×
Market median
-81% vs market
20202024
Debt / equity
30.36×
This company
0.62×
Market median
-4797% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (4) | ||
| Board of Directors | 2013 | |
| Chairman | 2013 | |
| Board of Directors | 2013 | |
| Board of Directors | 2013 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of TERAPIBYGG AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Dag Ramsli | Board of Directors | 0 companies |
| Frode Ueland | Chairman | 0 companies |
| Astrid Helene Olafsdottir | Board of Directors | 0 companies |
| Frode Een | Board of Directors | 0 companies |